1192801-08-3

Basic information

• Product Name: 2-[4-([3-tert-butoxycarobnylaminophenyl]amino)-6-[2-[4-[4-([3-tert-butoxycarbonylaminophenyl]amino)-6-chloro[1,3,5]triazine-2-ylamino]phenyl]ethylamino][1,3,5]triazine-2-ylamino]ethanol
• Synonyms: 2-[4-([3-tert-butoxycarobnylaminophenyl]amino)-6-[2-[4-[4-([3-tert-butoxycarbonylaminophenyl]amino)-6-chloro[1,3,5]triazine-2-ylamino]phenyl]ethylamino][1,3,5]triazine-2-ylamino]ethanol
• CAS NO: 1192801-08-3
• Molecular Weight: 800.32
• Mol File: 1192801-08-3.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 2-[4-([3-tert-butoxycarobnylaminophenyl]amino)-6-[2-[4-[4-([3-tert-butoxycarbonylaminophenyl]amino)-6-chloro[1,3,5]triazine-2-ylamino]phenyl]ethylamino][1,3,5]triazine-2-ylamino]ethanol(CAS DataBase Reference)
• NIST Chemistry Reference: 2-[4-([3-tert-butoxycarobnylaminophenyl]amino)-6-[2-[4-[4-([3-tert-butoxycarbonylaminophenyl]amino)-6-chloro[1,3,5]triazine-2-ylamino]phenyl]ethylamino][1,3,5]triazine-2-ylamino]ethanol(1192801-08-3)
• EPA Substance Registry System: 2-[4-([3-tert-butoxycarobnylaminophenyl]amino)-6-[2-[4-[4-([3-tert-butoxycarbonylaminophenyl]amino)-6-chloro[1,3,5]triazine-2-ylamino]phenyl]ethylamino][1,3,5]triazine-2-ylamino]ethanol(1192801-08-3)

Safety Data

• Hazardous Substances Data: 1192801-08-3(Hazardous Substances Data)

Upstream product

• 1192801-07-2 2-[4-[2-[4-aminophenyl]ethylamino]-6-([3-tert-butoxycarbonylaminophenyl]amino)[1,3,5]triazine-2-ylamino]ethanol 
• 537049-05-1 2-[3-(tert-butoxycarbonylamino)phenylamino]-4,6-dichloro-1,3,5-triazine 

Downstream Products

• 1192801-09-4 2-(4-(4-(4-(4-aminophenethylamino)-6-(3-(tert-butoxycarbonylamino)phenylamino)-1,3,5-triazin-2-ylamino)phenylethylamino)-6-(3-(tert-butoxycarbonylamino)phenylamino)-1,3,5-triazin-2-ylamino)ethanol 
• 1206607-22-8 2-(4-([3-tert-butoxycarbonylaminophenyl]amino)-6-(4-(2-(4-([3-tert-butoxycarbonylaminophenyl]amino)-6-(2-hydroxyethylamino)[1,3,5]triazin-2-ylamino)ethyl)phenylamino)[1,3,5]triazin-2-ylamino)ethanol 

Relevant articles and documents

2,4,6-Trisubstituted triazines as protein A mimetics for the treatment of autoimmune diseases

A first-in-class series of low molecular weight trisubstituted triazines were synthesized and evaluated for their ability tomimic proteinAbinding to human IgGantibody. The structure-activity relationship (SAR) demonstrates that the 1,3-phenylenediamine component was essential for robust activity. Twenty-two compounds, represented by lead molecule 34, displayed significant activity compared to protein A. These compounds may prove useful for the treatment of autoimmune disease.